Skip to main content
. 2023 Feb 1;15(3):915. doi: 10.3390/cancers15030915
177Lu-DOTA-TATE [177Lu]Lu[DOTA0-Tyr3]octreotate
BSA Bovine serum albumin
γH2AX Phosphorylated histone 2A
DAPI 4’,6-diamidino-2-phenylindole
DSB Double strand break
DMSO Dimethyl sulfoxide
GEP-NETs Gastroenteropancreatic-neuroendocrine tumors
HBSS Hanks balanced salt solution
IF Immunofluorescent
NETs Neuroendocrine tumors
PARP Poly(ADP-ribose)-polymerase
PARPi Poly(ADP-ribose)-polymerase inhibitor
PBS Phosphate buffered saline
PBST Phosphate buffered saline containing Triton X-100
PEG300 Polyethylene glycol 300
P-gp P-glycoprotein efflux pump
P.i. Post-injection
PRRT Peptide receptor radionuclide therapy
SSB Single strand break
SSTR2 Somatostatin receptor subtype 2
TTP Time to progression
UPLC-MS/MS Ultra performance liquid chromatography-tandem mass spectrometer